Trillium Software Positioned as a Leader in 2015 Magic

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Trillium Software Positioned as a Leader in 2015 Magic Quadrant for Data Quality Tools

BURLINGTON, MA--(Marketwired - Dec 1, 2015) -   Trillium Software , a Harte Hanks company ( NYSE : HHS ) and a leading provider of global data quality solutions, today announced that Gartner has, for the tenth straight year, positioned Trillium Software as a Leader in the Magic Quadrant for Data Quality Tools for 2015. Trillium believes its longevity in this independent report is unique in the market. Access the report by clicking HERE .

"We feel that being positioned as a Leader by Gartner in the data quality tools market represents the value and quality of our people, products and services," said Phil Galati, chief executive officer at Trillium Software. "In this new age of data quality, timely customer engagement and relevant interaction are the hallmark of improving the customer experience. Business professionals rely on an unprecedented amount of data to inform these interactions that drive revenue growth. They need solutions that allow them to discover, improve, prepare, and govern data with ease to ensure their current and future business initiatives are supported with accurate information."

According to the report, "leaders demonstrate strength across a full range of data quality functions, including profiling, parsing, standardization, matching, validation and enrichment. They exhibit a clear understanding and vision of where the market is headed, including recognition of multidomain data quality issues and delivery of enterprise-level data quality implementations. Leaders have an established market presence, significant size and a multinational presence (directly or as a result of a parent company)."

"Businesses need versatile data quality solutions that can adapt to rapidly changing data types and enterprise infrastructures," said Keith Kohl, vice president product management, Trillium Software. "With flexible on-premise and cloud-based deployment options, Trillium's global data quality solutions easily scale to Big Data and provide self-service data quality capabilities empower business users to quickly prepare, remediate and manage data quality so they can utilize better data for better business decisions."

The report also notes that "the data quality market continues to grow strongly. Gartner estimates that it reached $1.4 billion in software revenue at the end of 2014. This translates into 11.6% growth in constant-dollar terms over 2013, which had brought 11.9% growth over 2012. Gartner forecasts that this market's growth will accelerate during the next few years, to almost 14.4% by 2017, bringing the total to $2.1 billion. This market is among the fastest-growing in the enterprise software sector."

Magic Quadrant Disclaimer Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Trillium Software Trillium Software, a Harte Hanks company, is a leading, global enterprise data quality solutions provider. We enable business and IT leaders to anticipate opportunities, uncover hidden risks and make better decisions by rapidly providing them with complete, accurate and trusted data in everything they do. Trillium's full complement of technologies and services includes global data profiling, data cleansing, enrichment, and data linking for e-business, Big Data, customer relationship management, data governance, enterprise resource planning, supply chain management, data warehouse, and other enterprise applications. For more information about Trillium Software and its offerings, call (978) 436-8900 in the United States, +44 (0) 118 940 7666 in the United Kingdom, and +49 7031 714756 in Central Europe, or visit Trillium Software online at www.trilliumsoftware.com .

About Harte Hanks Harte Hanks ( NYSE : HHS ) is one of the world's leading, insight-driven multi-channel marketing organizations, delivering impactful business results for some of the world's best-known brands. Through strategic agencies and our core marketing services, we develop integrated solutions that connect brands with prospects and customers, moving them beyond awareness to transactions and brand loyalty. Visit the Harte Hanks website at www.HarteHanks.com or call (800) 456-9748.

As used herein, "Harte Hanks" refers to Harte Hanks, Inc. and/or its applicable operating subsidiaries, as the context may require. Trillium Software, Trillium Software System, as well as Harte Hanks' logo and name, are trademarks owned by Harte Hanks. All other brand names, product names, or trademarks belong to their respective owners.

(1) Gartner, Magic Quadrant for Data Quality Tools, Saul Judah, Ted Friedman, 18 November 2015

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Contact: Leonard Dubois 978-671-6133 leonard_dubois@trilliumsoftware.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 273

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 240

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 167

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 0

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 121

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 120

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 184

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Sentiment Shifts: Spotlight on Key Stocks with Puts

Updated Category News Views 232

Understanding Investor Sentiment Through Options Activity In the world of stock trading, monitoring investor sentiment is crucial. Retail investors frequently evaluate market movements based on buying and selling patterns. Yet, these activities can often mislead people about the true motivations behind traders' decisions. For example, purchasing shares may suggest...

Continue Reading
Solana Price Overview: Recent Trends and Market Insights

Updated Category News Views 50

Understanding Solana's Recent Price Behavior Solana's price has recently faced a decline of 3.66% within a 24-hour timeframe, settling at $150.80. Despite this short-term drop, its performance over the past week shows a more optimistic trend with a 5.0% increase from a previous value of $145.79. This fluctuation showcases the volatility often associated with...

Continue Reading
Navigating Market Cycles: Insights on E-Mini S&P 500 Movements

Updated Category News Views 216

Understanding the Current Market Cycle Dynamics The landscape of the E-Mini S&P 500 marks an intriguing phase as we enter the final quadrant of the master cycle that commenced with a significant low. This stage, specifically noted as the range of 270° to 360°, is where crucial market movements crystallize, setting the stage for prospective outcomes. As we analyze chart...

Continue Reading
Edgewell Personal Care Reports Q1 2025 Financial Performance

Updated Category News Views 297

Overview of Q1 Fiscal 2025 Results Edgewell Personal Care Company (NYSE: EPC) recently released its financial results for the first quarter of fiscal 2025, revealing a net sales figure of $478.4 million, representing a decrease of 2.1% compared to the same quarter last year. The decline reflects a 1.3% decrease in organic net sales, which excludes the effects of currency...

Continue Reading
Rockwell Automation Exceeds Expectations in Fiscal Q1 2025

Updated Category News Views 412

Rockwell Automation Sees Strong First Quarter Performance Rockwell Automation, Inc. (NYSE: ROK) has announced its fiscal Q1 2025 results, showcasing a remarkable performance that exceeded market expectations. Under the leadership of Blake Moret, Chairman and CEO, the company reported a combination of improved margins and earnings per share (EPS) this quarter, attributed...

Continue Reading